Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 62 entries
Sorted by: Best Match Show Resources per page
Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels.

AIDS research and treatment

Duran L, Rodriguez C, Drozd D, Nance RM, Delaney JA, Burkholder G, Mugavero MJ, Willig JH, Warriner AH, Crane PK, Atkinson BE, Harrington RD, Dhanireddy S, Saag MS, Kitahata MM, Crane HM.
PMID: 26273478
AIDS Res Treat. 2015;2015:478750. doi: 10.1155/2015/478750. Epub 2015 Jul 26.

Fructosamine is an alternative method to hemoglobin A1c (HbA1c) for determining average glycemia. However, its use has not been extensively evaluated in persons living with HIV (PLWH). We examined the relationship between HbA1c and fructosamine values, specifically focusing on...

Cite
Duran L, Rodriguez C, Drozd D, et al. Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels. AIDS Res Treat. 2015;2015:478750doi: 10.1155/2015/478750.
Duran, L., Rodriguez, C., Drozd, D., Nance, R. M., Delaney, J. A., Burkholder, G., Mugavero, M. J., Willig, J. H., Warriner, A. H., Crane, P. K., Atkinson, B. E., Harrington, R. D., Dhanireddy, S., Saag, M. S., Kitahata, M. M., & Crane, H. M. (2015). Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels. AIDS research and treatment, 2015478750. https://doi.org/10.1155/2015/478750
Duran, Luisa, et al. "Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels." AIDS research and treatment vol. 2015 (2015): 478750. doi: https://doi.org/10.1155/2015/478750
Duran L, Rodriguez C, Drozd D, Nance RM, Delaney JA, Burkholder G, Mugavero MJ, Willig JH, Warriner AH, Crane PK, Atkinson BE, Harrington RD, Dhanireddy S, Saag MS, Kitahata MM, Crane HM. Fructosamine and Hemoglobin A1c Correlations in HIV-Infected Adults in Routine Clinical Care: Impact of Anemia and Albumin Levels. AIDS Res Treat. 2015;2015:478750. doi: 10.1155/2015/478750. Epub 2015 Jul 26. PMID: 26273478; PMCID: PMC4529884.
Copy Download .nbib Format: NLM
HIV care at a crossroads: the emerging crisis in the US HIV epidemic.

MedGenMed : Medscape general medicine

Mugavero MJ, Saag MS.
PMID: 17435658
MedGenMed. 2007 Mar 23;9(1):58.

No abstract available.

Cite
Mugavero MJ, Saag MS. HIV care at a crossroads: the emerging crisis in the US HIV epidemic. MedGenMed. 2007;9(1):58
Mugavero, M. J., & Saag, M. S. (2007). HIV care at a crossroads: the emerging crisis in the US HIV epidemic. MedGenMed : Medscape general medicine, 9(1), 58.
Mugavero, Michael J, and Saag, Michael S. "HIV care at a crossroads: the emerging crisis in the US HIV epidemic." MedGenMed : Medscape general medicine vol. 9,1 (2007): 58.
Mugavero MJ, Saag MS. HIV care at a crossroads: the emerging crisis in the US HIV epidemic. MedGenMed. 2007 Mar 23;9(1):58. PMID: 17435658; PMCID: PMC1924992.
Copy Download .nbib Format: NLM
A conceptual framework for understanding chronic pain in patients with HIV.

Pain practice : the official journal of World Institute of Pain

Merlin JS, Zinski A, Norton WE, Ritchie CS, Saag MS, Mugavero MJ, Treisman G, Hooten WM.
PMID: 23551857
Pain Pract. 2014 Mar;14(3):207-16. doi: 10.1111/papr.12052. Epub 2013 Apr 01.

Chronic pain is common in persons with HIV and is often associated with psychiatric illness and substance abuse. Current literature links psychiatric illness and substance abuse with worse HIV outcomes; however, the relationship of chronic pain, alone and in...

Cite
Merlin JS, Zinski A, Norton WE, et al. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2013;14(3):207-16doi: 10.1111/papr.12052.
Merlin, J. S., Zinski, A., Norton, W. E., Ritchie, C. S., Saag, M. S., Mugavero, M. J., Treisman, G., & Hooten, W. M. (2014). A conceptual framework for understanding chronic pain in patients with HIV. Pain practice : the official journal of World Institute of Pain, 14(3), 207-16. https://doi.org/10.1111/papr.12052
Merlin, Jessica S, et al. "A conceptual framework for understanding chronic pain in patients with HIV." Pain practice : the official journal of World Institute of Pain vol. 14,3 (2014): 207-16. doi: https://doi.org/10.1111/papr.12052
Merlin JS, Zinski A, Norton WE, Ritchie CS, Saag MS, Mugavero MJ, Treisman G, Hooten WM. A conceptual framework for understanding chronic pain in patients with HIV. Pain Pract. 2014 Mar;14(3):207-16. doi: 10.1111/papr.12052. Epub 2013 Apr 01. PMID: 23551857.
Copy Download .nbib Format: NLM
Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration.

Journal of clinical medicine

Ingle SM, Crane HM, Glass TR, Yip B, Lima VD, Gill MJ, Hanhoff N, Ammassari A, Mugavero MJ, Tate JP, Guest J, Turner NL, May MT, Sterne JAC.
PMID: 30301179
J Clin Med. 2018 Oct 05;7(10). doi: 10.3390/jcm7100328.

Adherence to antiretroviral therapy (ART) is critical for successful treatment of Human Immunodeficiency Virus (HIV), but comparisons across settings are difficult because adherence is measured in different ways. We examined utility of different adherence measures for identification of patients...

Cite
Ingle SM, Crane HM, Glass TR, et al. Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration. J Clin Med. 2018;7(10)doi: 10.3390/jcm7100328.
Ingle, S. M., Crane, H. M., Glass, T. R., Yip, B., Lima, V. D., Gill, M. J., Hanhoff, N., Ammassari, A., Mugavero, M. J., Tate, J. P., Guest, J., Turner, N. L., May, M. T., & Sterne, J. A. C. (2018). Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration. Journal of clinical medicine, 7(10), . https://doi.org/10.3390/jcm7100328
Ingle, Suzanne M, et al. "Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration." Journal of clinical medicine vol. 7,10 (2018). doi: https://doi.org/10.3390/jcm7100328
Ingle SM, Crane HM, Glass TR, Yip B, Lima VD, Gill MJ, Hanhoff N, Ammassari A, Mugavero MJ, Tate JP, Guest J, Turner NL, May MT, Sterne JAC. Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration. J Clin Med. 2018 Oct 05;7(10). doi: 10.3390/jcm7100328. PMID: 30301179; PMCID: PMC6209956.
Copy Download .nbib Format: NLM
Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus.

Open forum infectious diseases

Kay ES, Batey DS, Westfall AO, Christopoulos K, Cole SR, Geng EH, Mathews WC, Moore RD, Mugavero MJ.
PMID: 31041339
Open Forum Infect Dis. 2019 Mar 07;6(4):ofz120. doi: 10.1093/ofid/ofz120. eCollection 2019 Apr.

BACKGROUND: To obtain optimal health outcomes, persons living with human immunodeficiency virus (HIV) must be retained in clinical care. We examined the relationships between 4 possible combinations of 2 separate retention measures (missed visits and the Institute of Medicine...

Cite
Kay ES, Batey DS, Westfall AO, et al. Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019;6(4):ofz120doi: 10.1093/ofid/ofz120.
Kay, E. S., Batey, D. S., Westfall, A. O., Christopoulos, K., Cole, S. R., Geng, E. H., Mathews, W. C., Moore, R. D., & Mugavero, M. J. (2019). Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus. Open forum infectious diseases, 6(4), ofz120. https://doi.org/10.1093/ofid/ofz120
Kay, Emma Sophia, et al. "Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus." Open forum infectious diseases vol. 6,4 (2019): ofz120. doi: https://doi.org/10.1093/ofid/ofz120
Kay ES, Batey DS, Westfall AO, Christopoulos K, Cole SR, Geng EH, Mathews WC, Moore RD, Mugavero MJ. Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Mar 07;6(4):ofz120. doi: 10.1093/ofid/ofz120. eCollection 2019 Apr. PMID: 31041339; PMCID: PMC6483128.
Copy Download .nbib Format: NLM
Care Continuum and Postdischarge Outcomes Among HIV-Infected Adults Admitted to the Hospital in Zambia.

Open forum infectious diseases

Haachambwa L, Kandiwo N, Zulu PM, Rutagwera D, Geng E, Holmes CB, Sinkala E, Claassen CW, Mugavero MJ, Wa Mwanza M, Turan JM, Vinikoor MJ.
PMID: 31660330
Open Forum Infect Dis. 2019 Jul 16;6(10):ofz336. doi: 10.1093/ofid/ofz336. eCollection 2019 Oct.

BACKGROUND: We characterized the extent of antiretroviral therapy (ART) experience and postdischarge mortality among hospitalized HIV-infected adults in Zambia.METHODS: At a central hospital with an opt-out HIV testing program, we enrolled HIV-infected adults (18+ years) admitted to internal medicine...

Cite
Haachambwa L, Kandiwo N, Zulu PM, et al. Care Continuum and Postdischarge Outcomes Among HIV-Infected Adults Admitted to the Hospital in Zambia. Open Forum Infect Dis. 2019;6(10):ofz336doi: 10.1093/ofid/ofz336.
Haachambwa, L., Kandiwo, N., Zulu, P. M., Rutagwera, D., Geng, E., Holmes, C. B., Sinkala, E., Claassen, C. W., Mugavero, M. J., Wa Mwanza, M., Turan, J. M., & Vinikoor, M. J. (2019). Care Continuum and Postdischarge Outcomes Among HIV-Infected Adults Admitted to the Hospital in Zambia. Open forum infectious diseases, 6(10), ofz336. https://doi.org/10.1093/ofid/ofz336
Haachambwa, Lottie, et al. "Care Continuum and Postdischarge Outcomes Among HIV-Infected Adults Admitted to the Hospital in Zambia." Open forum infectious diseases vol. 6,10 (2019): ofz336. doi: https://doi.org/10.1093/ofid/ofz336
Haachambwa L, Kandiwo N, Zulu PM, Rutagwera D, Geng E, Holmes CB, Sinkala E, Claassen CW, Mugavero MJ, Wa Mwanza M, Turan JM, Vinikoor MJ. Care Continuum and Postdischarge Outcomes Among HIV-Infected Adults Admitted to the Hospital in Zambia. Open Forum Infect Dis. 2019 Jul 16;6(10):ofz336. doi: 10.1093/ofid/ofz336. eCollection 2019 Oct. PMID: 31660330; PMCID: PMC6778319.
Copy Download .nbib Format: NLM
Insomnia and Risk of Myocardial Infarction Among People with HIV.

Journal of acquired immune deficiency syndromes (1999)

Luu BR, Nance RM, Delaney JAC, Ruderman SA, Heckbert SR, Budoff MJ, Mathews WC, Moore RD, Feinstein MJ, Burkholder GA, Eron JJ, Mugavero MJ, Saag MS, Kitahata MM, Crane HM, Whitney BM.
PMID: 35001042
J Acquir Immune Defic Syndr. 2022 Jan 06; doi: 10.1097/QAI.0000000000002910. Epub 2022 Jan 06.

BACKGROUND: Insomnia is common among people with HIV (PWH) and may be associated with increased risk of myocardial infarction (MI). This study examines the association between insomnia and MI by MI type among PWH.SETTING: Longitudinal cohort study of PWH...

Cite
Luu BR, Nance RM, Delaney JAC, et al. Insomnia and Risk of Myocardial Infarction Among People with HIV. J Acquir Immune Defic Syndr. 2022;doi: 10.1097/QAI.0000000000002910.
Luu, B. R., Nance, R. M., Delaney, J. A. C., Ruderman, S. A., Heckbert, S. R., Budoff, M. J., Mathews, W. C., Moore, R. D., Feinstein, M. J., Burkholder, G. A., Eron, J. J., Mugavero, M. J., Saag, M. S., Kitahata, M. M., Crane, H. M., & Whitney, B. M. (2022). Insomnia and Risk of Myocardial Infarction Among People with HIV. Journal of acquired immune deficiency syndromes (1999), . https://doi.org/10.1097/QAI.0000000000002910
Luu, Brandon R, et al. "Insomnia and Risk of Myocardial Infarction Among People with HIV." Journal of acquired immune deficiency syndromes (1999) vol. (2022). doi: https://doi.org/10.1097/QAI.0000000000002910
Luu BR, Nance RM, Delaney JAC, Ruderman SA, Heckbert SR, Budoff MJ, Mathews WC, Moore RD, Feinstein MJ, Burkholder GA, Eron JJ, Mugavero MJ, Saag MS, Kitahata MM, Crane HM, Whitney BM. Insomnia and Risk of Myocardial Infarction Among People with HIV. J Acquir Immune Defic Syndr. 2022 Jan 06; doi: 10.1097/QAI.0000000000002910. Epub 2022 Jan 06. PMID: 35001042.
Copy Download .nbib Format: NLM
Corrigendum to: The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11.

International journal of epidemiology

Lesko CR, Cole SR, Hall HI, Westreich D, Miller WC, Eron JJ, Li J, Mugavero MJ.
PMID: 33993279
Int J Epidemiol. 2021 Jul 09;50(3):1044. doi: 10.1093/ije/dyab102.

No abstract available.

Cite
Lesko CR, Cole SR, Hall HI, et al. Corrigendum to: The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11. Int J Epidemiol. 2021;50(3):1044doi: 10.1093/ije/dyab102.
Lesko, C. R., Cole, S. R., Hall, H. I., Westreich, D., Miller, W. C., Eron, J. J., Li, J., Mugavero, M. J. (2021). Corrigendum to: The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11. International journal of epidemiology, 50(3), 1044. https://doi.org/10.1093/ije/dyab102
Lesko, Catherine R, et al. "Corrigendum to: The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11." International journal of epidemiology vol. 50,3 (2021): 1044. doi: https://doi.org/10.1093/ije/dyab102
Lesko CR, Cole SR, Hall HI, Westreich D, Miller WC, Eron JJ, Li J, Mugavero MJ. Corrigendum to: The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11. Int J Epidemiol. 2021 Jul 09;50(3):1044. doi: 10.1093/ije/dyab102. PMID: 33993279; PMCID: PMC8485670.
Copy Download .nbib Format: NLM
Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

De Nunzio C, Lombardo R, Baldassarri V, Cindolo L, Bertolo R, Minervini A, Sessa F, Muto G, Bove P, Vittori M, Bozzini G, Castellan P, Mugavero F, Falsaperla M, Schips L, Celia A, Bada M, Porreca A, Pastore A, Al Salhi Y, Giampaoli M, Novella G, Rizzetto R, Trabacchin N, Mantica G, Pini G, Remmers S, Antonelli A, Tubaro A.
PMID: 33965292
Eur J Surg Oncol. 2021 Oct;47(10):2640-2645. doi: 10.1016/j.ejso.2021.04.033. Epub 2021 Apr 30.

OBJECTIVES: The Rotterdam Prostate Cancer Risk calculator (RPCRC) has been validated in the past years. Recently a new version including multiparametric magnetic resonance imaging (mpMRI) data has been released. The aim of our study was to analyze the performance...

Cite
De Nunzio C, Lombardo R, Baldassarri V, et al. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation. Eur J Surg Oncol. 2021;47(10):2640-2645doi: 10.1016/j.ejso.2021.04.033.
De Nunzio, C., Lombardo, R., Baldassarri, V., Cindolo, L., Bertolo, R., Minervini, A., Sessa, F., Muto, G., Bove, P., Vittori, M., Bozzini, G., Castellan, P., Mugavero, F., Falsaperla, M., Schips, L., Celia, A., Bada, M., Porreca, A., Pastore, A., Al Salhi, Y., Giampaoli, M., Novella, G., Rizzetto, R., Trabacchin, N., Mantica, G., Pini, G., Remmers, S., Antonelli, A., & Tubaro, A. (2021). Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 47(10), 2640-2645. https://doi.org/10.1016/j.ejso.2021.04.033
De Nunzio, Cosimo, et al. "Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation." European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology vol. 47,10 (2021): 2640-2645. doi: https://doi.org/10.1016/j.ejso.2021.04.033
De Nunzio C, Lombardo R, Baldassarri V, Cindolo L, Bertolo R, Minervini A, Sessa F, Muto G, Bove P, Vittori M, Bozzini G, Castellan P, Mugavero F, Falsaperla M, Schips L, Celia A, Bada M, Porreca A, Pastore A, Al Salhi Y, Giampaoli M, Novella G, Rizzetto R, Trabacchin N, Mantica G, Pini G, Remmers S, Antonelli A, Tubaro A. Rotterdam mobile phone app including MRI data for the prediction of prostate cancer: A multicenter external validation. Eur J Surg Oncol. 2021 Oct;47(10):2640-2645. doi: 10.1016/j.ejso.2021.04.033. Epub 2021 Apr 30. PMID: 33965292.
Copy Download .nbib Format: NLM
Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review.

Brain sciences

Figorilli M, Lanza G, Congiu P, Lecca R, Casaglia E, Mogavero MP, Puligheddu M, Ferri R.
PMID: 34942893
Brain Sci. 2021 Nov 30;11(12). doi: 10.3390/brainsci11121588.

REM sleep without atonia (RSWA) is the polysomnographic (PSG) hallmark of rapid eye movement (REM) sleep behavior disorder (RBD), a feature essential for the diagnosis of this condition. Several additional neurophysiological aspects of this complex disorder have also recently...

Cite
Figorilli M, Lanza G, Congiu P, et al. Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review. Brain Sci. 2021;11(12)doi: 10.3390/brainsci11121588.
Figorilli, M., Lanza, G., Congiu, P., Lecca, R., Casaglia, E., Mogavero, M. P., Puligheddu, M., & Ferri, R. (2021). Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review. Brain sciences, 11(12), . https://doi.org/10.3390/brainsci11121588
Figorilli, Michela, et al. "Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review." Brain sciences vol. 11,12 (2021). doi: https://doi.org/10.3390/brainsci11121588
Figorilli M, Lanza G, Congiu P, Lecca R, Casaglia E, Mogavero MP, Puligheddu M, Ferri R. Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review. Brain Sci. 2021 Nov 30;11(12). doi: 10.3390/brainsci11121588. PMID: 34942893; PMCID: PMC8699681.
Copy Download .nbib Format: NLM
Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder.

Sleep medicine

DelRosso LM, Ferri R, Chen ML, Kapoor V, Allen RP, Mogavero MP, Picchietti DL.
PMID: 34562823
Sleep Med. 2021 Nov;87:114-118. doi: 10.1016/j.sleep.2021.08.030. Epub 2021 Sep 08.

BACKGROUND: Iron supplementation is the most commonly considered treatment option for children with restless legs syndrome (RLS) or periodic limb movement disorder (PLMD); however, there is a scarcity of evidence on the effectiveness of intravenous preparations. In this study,...

Cite
DelRosso LM, Ferri R, Chen ML, et al. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder. Sleep Med. 2021;87:114-118doi: 10.1016/j.sleep.2021.08.030.
DelRosso, L. M., Ferri, R., Chen, M. L., Kapoor, V., Allen, R. P., Mogavero, M. P., & Picchietti, D. L. (2021). Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder. Sleep medicine, 87114-118. https://doi.org/10.1016/j.sleep.2021.08.030
DelRosso, Lourdes M, et al. "Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder." Sleep medicine vol. 87 (2021): 114-118. doi: https://doi.org/10.1016/j.sleep.2021.08.030
DelRosso LM, Ferri R, Chen ML, Kapoor V, Allen RP, Mogavero MP, Picchietti DL. Clinical efficacy and safety of intravenous ferric carboxymaltose treatment of pediatric restless legs syndrome and periodic limb movement disorder. Sleep Med. 2021 Nov;87:114-118. doi: 10.1016/j.sleep.2021.08.030. Epub 2021 Sep 08. PMID: 34562823.
Copy Download .nbib Format: NLM
Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection.

mBio

Sohn SY, Hearing J, Mugavero J, Kirillov V, Gorbunova E, Helminiak L, Mishra S, Mackow E, Hearing P, Reich NC, Kim HK.
PMID: 34724828
mBio. 2021 Dec 21;12(6):e0275621. doi: 10.1128/mBio.02756-21. Epub 2021 Nov 02.

Outbreaks of emerging viral pathogens like severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are a major medical challenge. There is a pressing need for antivirals that can be rapidly deployed to curb infection and dissemination. We determined the efficacy...

Cite
Sohn SY, Hearing J, Mugavero J, et al. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection. mBio. 2021;12(6):e0275621doi: 10.1128/mBio.02756-21.
Sohn, S. Y., Hearing, J., Mugavero, J., Kirillov, V., Gorbunova, E., Helminiak, L., Mishra, S., Mackow, E., Hearing, P., Reich, N. C., & Kim, H. K. (2021). Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection. mBio, 12(6), e0275621. https://doi.org/10.1128/mBio.02756-21
Sohn, Sook-Young, et al. "Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection." mBio vol. 12,6 (2021): e0275621. doi: https://doi.org/10.1128/mBio.02756-21
Sohn SY, Hearing J, Mugavero J, Kirillov V, Gorbunova E, Helminiak L, Mishra S, Mackow E, Hearing P, Reich NC, Kim HK. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection. mBio. 2021 Dec 21;12(6):e0275621. doi: 10.1128/mBio.02756-21. Epub 2021 Nov 02. PMID: 34724828; PMCID: PMC8561397.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 62 entries